15% off on your first order with code WELCOME15. Up to 10% off when you buy a stack. 5 · 7.5 · 10% off on 3, 6 or 9 of the same vial. Same-day dispatch on orders before 12:00 SAST, business days.

◂ RESEARCH LIBRARY
Cerebrolysin research peptide

Research Overview

Cerebrolysin

Neuro Recovery & Clarity

HPLC-verified 98%Batch CoAResearch use only

OVERVIEW

Cerebrolysin (Neuro Recovery & Clarity) is a research-grade peptide supplied by Living Water Labs for laboratory investigation. Neurotrophic peptide mixture for neuroregeneration research. Each batch is HPLC-verified to a minimum 98% purity with a batch-specific Certificate of Analysis. The summary below outlines documented mechanisms and study areas reported in the research literature.

Scientific name

Neuropeptide preparation (Cerebrolysin)

Molecular weight

Peptide mixture (<10,000 Da fraction)

Purity

98.6%

Vial size

60mg

DOCUMENTED RESEARCH AREAS

  • Mimics the action of endogenous neurotrophic factors (BDNF, GDNF, NGF, CNTF) in preclinical models
  • Supports neuronal survival and reduces apoptosis under ischaemic and hypoxic conditions
  • Promotes synaptogenesis and neuroplasticity in cognitive-performance research
  • Modulates amyloid precursor protein processing in neurodegeneration models
  • Reduces neuroinflammation and oxidative stress in injured neural tissue
  • Studied across stroke, traumatic brain injury, and dementia research paradigms
  • Multi-target pleiotropic action distinct from single-receptor neuropeptides

MECHANISM OF ACTION

Cerebrolysin is a preparation of low-molecular-weight neuropeptides and amino acids derived from porcine brain. Research describes neurotrophic-like activity — supporting neuronal survival, plasticity and repair signalling — and it has been studied clinically in dementia and stroke.

  • Contains neuropeptide fragments with reported neurotrophic-like activity
  • Studied for effects on neuronal survival and synaptic plasticity
  • Evaluated in dementia and post-stroke clinical trials

STUDY SUMMARIES

4 peer-reviewed references

Drugs Today (Barc) · 2012

The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair

A pharmacology review of Cerebrolysin reported neurotrophic mechanisms of brain protection and repair.

View on PubMed (PMID 22514792)

Cochrane Database Syst Rev · 2019

Cerebrolysin for vascular dementia

A Cochrane systematic review assessing the evidence for Cerebrolysin in vascular dementia.

View on PubMed (PMID 31710397)

J Neural Transm Suppl · 2002

Sustained improvement of cognition and global function in patients with moderately severe Alzheimer’s disease

A trial reporting sustained cognitive and global-function outcomes with Cerebrolysin in moderately severe Alzheimer’s disease.

View on PubMed (PMID 12456069)

CITATIONS

  1. 1.The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair. Drugs Today (Barc). 2012. PMID 22514792. pubmed.ncbi.nlm.nih.gov/22514792
  2. 2.Cerebrolysin: a review of its use in dementia. Drugs Aging. 2009. PMID 19848437. pubmed.ncbi.nlm.nih.gov/19848437
  3. 3.Cerebrolysin for vascular dementia. Cochrane Database Syst Rev. 2019. PMID 31710397. pubmed.ncbi.nlm.nih.gov/31710397
  4. 4.Sustained improvement of cognition and global function in patients with moderately severe Alzheimer’s disease. J Neural Transm Suppl. 2002. PMID 12456069. pubmed.ncbi.nlm.nih.gov/12456069

Citations describe findings reported in the referenced preclinical, in-vitro or clinical literature. They are provided for research and educational purposes only and are not a therapeutic claim.

All information is provided for research and educational purposes only and describes findings in preclinical/in-vitro literature. Not medical advice. Products are supplied strictly for research purposes — not for human consumption.

Related Research & Reading

Keep exploring — goal collections, plain-language guides and the wellness journal, all in one place.